论文部分内容阅读
Glucagon-like peptide-1 (GLP-1) and its long-acting analogues have neuroprotective and neurotrophic properties and are emerging as potential treatments for neurodegenerative diseases.Its short half-life has limited the application of GLP-1 in the clinic.W